The chromatography columns market has witnessed significant growth in the adoption of prepacked chromatography columns. Prepacked columns combine gel and buffer in a single-use disposable cartridge, saving labor costs and reducing the risk of contamination. Key advantages include simplified chromatography setup, validation of separation conditions, and reduced method development times.
The global prepacked chromatography columns market is estimated to be valued at US$ 354.36 Million in 2024 and is expected to exhibit a CAGR of 4.0% over the forecast period from 2024 to 2030.
Key Takeaways
Key players operating in The Prepacked Chromatography Columns Market are ExxonMobil Corp., Pennzoil, Quaker Chemical Corp., Royal Dutch Shell Co, British Petroleum, Chevron Corp., Total S.A, JX Nippon Oil & Energy Corp., Lukoil, and Philips 66 Company. These players are focusing on new product launches and partnerships to expand their market share.
The growing demand from the pharmaceutical and biotechnology industries is a major factor driving the growth of the prepacked chromatography columns market. Rapid diagnostic kits for COVID-19 require extensive use of prepacked columns for purification, contributing to demand growth.
North America dominated the market in 2019 owing to presence of key pharmaceutical companies and availability of funds for research. However, the Asia Pacific region is expected to witness the highest growth over the forecast period due to expansion of biotech industry in China and India.
Market Key Trends
The key trend gaining traction in the prepacked chromatography columns market is the shift towards eco-friendly columns. Players are focusing on green chromatography and offering biodegradable and recyclable products produced from renewable resources. For example, ExxonMobil has developed porous polymeric beads made from corn for prepacked columns with lower carbon footprint. Additionally, growth inCRO (Contract Research Organization) facilities globally and increasing R&D investments by biopharma companies for vaccine and drug development is expected to boost adoptio nof prepacked columns through 2030.
Porter’s Analysis
Threat of new entrants: Regulations on chromatography equipment manufacturing and high start up costs reduce threat.
Bargaining power of buyers: Large buyers like pharmaceutical companies can negotiate lower prices but suppliers have product differentiation advantage.
Bargaining power of suppliers: Major suppliers have established relationships with equipment manufacturers reducing their power.
Threat of new substitutes: Though some alternatives exist, chromatography remains gold standard analysis technique reducing threat of substitution.
Competitive rivalry: Industry dominated by few global players however local and regional suppliers increase competition on price and delivery.
Geographically, North America accounts for the largest value share in the prepacked chromatography columns market due to established life sciences industry and pharmaceutical R&D spending. The region is expected to continue its dominance over the forecast period. Asia Pacific is projected to be the fastest growing market powered by expansion of bioprocessing and biopharmaceutical production capacities in countries like China and India. Economic development is driving increased healthcare investments and demand for advanced technologies.
The prepacked chromatography columns market for 2024 is estimated at US$ 354.36 million based on a CAGR of 4.0% for the forecast period of 2024 to 2030. Key players in the market are ExxonMobil Corp., Pennzoil, Quaker Chemical Corp., Royal Dutch Shell Co, British Petroleum, Chevron Corp., Total S.A, JX Nippon Oil & Energy Corp., Lukoil, and Philips 66 Company.